BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33011741)

  • 1. Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapy.
    Steggink LC; Boer H; Meijer C; Lefrandt JD; Terstappen LWMM; Fehrmann RSN; Gietema JA
    Pharmacogenomics J; 2021 Apr; 21(2):152-164. PubMed ID: 33011741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.
    de Haas EC; Zwart N; Meijer C; Nuver J; Boezen HM; Suurmeijer AJ; Hoekstra HJ; van der Steege G; Sleijfer DT; Gietema JA
    J Clin Oncol; 2008 Apr; 26(11):1817-23. PubMed ID: 18398146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic landscape of platinum resistant and sensitive testicular cancers.
    Loveday C; Litchfield K; Proszek PZ; Cornish AJ; Santo F; Levy M; Macintyre G; Holryod A; Broderick P; Dudakia D; Benton B; Bakir MA; Hiley C; Grist E; Swanton C; Huddart R; Powles T; Chowdhury S; Shipley J; O'Connor S; Brenton JD; Reid A; de Castro DG; Houlston RS; Turnbull C
    Nat Commun; 2020 May; 11(1):2189. PubMed ID: 32366847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predisposition alleles for Testicular Germ Cell Tumour.
    Rapley EA; Nathanson KL
    Curr Opin Genet Dev; 2010 Jun; 20(3):225-30. PubMed ID: 20303738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Dose Chemotherapy in a Late Relapse, Platinum-Refractory Nonseminomatous Germ Cell Tumor.
    Connell BJ; Patel MJ; Tretter CG
    Clin Genitourin Cancer; 2016 Aug; 14(4):e441-3. PubMed ID: 27055370
    [No Abstract]   [Full Text] [Related]  

  • 6. Common variants identified in genome-wide association studies of testicular germ cell tumour: an update, biological insights and clinical application.
    Litchfield K; Shipley J; Turnbull C
    Andrology; 2015 Jan; 3(1):34-46. PubMed ID: 25598472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
    Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
    Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of four new susceptibility loci for testicular germ cell tumour.
    Litchfield K; Holroyd A; Lloyd A; Broderick P; Nsengimana J; Eeles R; Easton DF; Dudakia D; Bishop DT; Reid A; Huddart RA; Grotmol T; Wiklund F; Shipley J; Houlston RS; Turnbull C
    Nat Commun; 2015 Oct; 6():8690. PubMed ID: 26503584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology of germ cell tumors.
    Ma YT; Cullen MH; Hussain SA
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):457-71, vii. PubMed ID: 21570602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association studies provide new insights into the genetic basis of testicular germ-cell tumour.
    Turnbull C; Rahman N
    Int J Androl; 2011 Aug; 34(4 Pt 2):e86-96; discussion e96-7. PubMed ID: 21623831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the FSHR 2039A>G variant associated with susceptibility to testicular germ cell cancer?
    Bang AK; Busch AS; Almstrup K; Gromoll J; Kliesch S; Rajpert-De Meyts E; Skakkebaek NE; Juul A; Tüttelmann F; Jørgensen N
    Andrology; 2018 Jan; 6(1):176-183. PubMed ID: 29179257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide association study of men with symptoms of testicular dysgenesis syndrome and its network biology interpretation.
    Dalgaard MD; Weinhold N; Edsgärd D; Silver JD; Pers TH; Nielsen JE; Jørgensen N; Juul A; Gerds TA; Giwercman A; Giwercman YL; Cohn-Cedermark G; Virtanen HE; Toppari J; Daugaard G; Jensen TS; Brunak S; Rajpert-De Meyts E; Skakkebæk NE; Leffers H; Gupta R
    J Med Genet; 2012 Jan; 49(1):58-65. PubMed ID: 22140272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.
    Fung C; Fossa SD; Milano MT; Sahasrabudhe DM; Peterson DR; Travis LB
    J Clin Oncol; 2015 Oct; 33(28):3105-15. PubMed ID: 26240226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cis-Diammine-1, 1-cyclobutane dicarboxylate platinum II (carboplatin) in the treatment of testicular germ-cell tumours: a preliminary report.
    Peckham MJ; Horwich A; Brada M; Drury A; Hendry WF
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():101-10. PubMed ID: 3002622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.
    Turnbull C; Rapley EA; Seal S; Pernet D; Renwick A; Hughes D; Ricketts M; Linger R; Nsengimana J; Deloukas P; Huddart RA; Bishop DT; Easton DF; Stratton MR; Rahman N;
    Nat Genet; 2010 Jul; 42(7):604-7. PubMed ID: 20543847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying the heritability of testicular germ cell tumour using both population-based and genomic approaches.
    Litchfield K; Thomsen H; Mitchell JS; Sundquist J; Houlston RS; Hemminki K; Turnbull C
    Sci Rep; 2015 Sep; 5():13889. PubMed ID: 26349679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy.
    Trendowski MR; El-Charif O; Ratain MJ; Monahan P; Mu Z; Wheeler HE; Dinh PC; Feldman DR; Ardeshir-Rouhani-Fard S; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Mushiroda T; Kubo M; Hannigan R; Strathmann F; Einhorn LH; Fossa SD; Travis LB; Dolan ME
    Clin Cancer Res; 2019 Oct; 25(19):5913-5924. PubMed ID: 31296530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial.
    Subbiah V; Meric-Bernstam F; Mills GB; Shaw KR; Bailey AM; Rao P; Ward JF; Pagliaro LC
    J Hematol Oncol; 2014 Aug; 7():52. PubMed ID: 25085632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy.
    Necchi A; Bratslavsky G; Corona RJ; Chung JH; Millis SZ; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Severson E; Daniel S; Killian JK; Ali SM; Schrock AB; Reddy P; Miller VA; Welsh A; Gay LM; Ross JS
    Eur Urol Focus; 2020 Jan; 6(1):122-130. PubMed ID: 30025711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor.
    Wang Z; McGlynn KA; Rajpert-De Meyts E; Bishop DT; Chung CC; Dalgaard MD; Greene MH; Gupta R; Grotmol T; Haugen TB; Karlsson R; Litchfield K; Mitra N; Nielsen K; Pyle LC; Schwartz SM; Thorsson V; Vardhanabhuti S; Wiklund F; Turnbull C; Chanock SJ; Kanetsky PA; Nathanson KL;
    Nat Genet; 2017 Jul; 49(7):1141-1147. PubMed ID: 28604732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.